[go: up one dir, main page]

NO20000706L - Metode for økning av biotilgjengeligheten av fexofenadin og dens derivater - Google Patents

Metode for økning av biotilgjengeligheten av fexofenadin og dens derivater

Info

Publication number
NO20000706L
NO20000706L NO20000706A NO20000706A NO20000706L NO 20000706 L NO20000706 L NO 20000706L NO 20000706 A NO20000706 A NO 20000706A NO 20000706 A NO20000706 A NO 20000706A NO 20000706 L NO20000706 L NO 20000706L
Authority
NO
Norway
Prior art keywords
fexofenadine
bioavailability
derivatives
increasing
Prior art date
Application number
NO20000706A
Other languages
English (en)
Other versions
NO325148B1 (no
NO20000706D0 (no
Inventor
Kin-Kai Hwang
Dennis H Giesing
Gail H Hurst
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO20000706D0 publication Critical patent/NO20000706D0/no
Publication of NO20000706L publication Critical patent/NO20000706L/no
Publication of NO325148B1 publication Critical patent/NO325148B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20000706A 1997-08-14 2000-02-11 Farmasoytisk preparat og anvendelse av en sammensetning ved fremstilling av et medikament for behandling av allergiske reaksjoner NO325148B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (3)

Publication Number Publication Date
NO20000706D0 NO20000706D0 (no) 2000-02-11
NO20000706L true NO20000706L (no) 2000-04-13
NO325148B1 NO325148B1 (no) 2008-02-11

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000706A NO325148B1 (no) 1997-08-14 2000-02-11 Farmasoytisk preparat og anvendelse av en sammensetning ved fremstilling av et medikament for behandling av allergiske reaksjoner

Country Status (29)

Country Link
EP (1) EP1003528B1 (no)
JP (1) JP4295913B2 (no)
KR (1) KR100522985B1 (no)
CN (1) CN1143680C (no)
AR (1) AR018505A1 (no)
AT (1) ATE224721T1 (no)
AU (1) AU725965C (no)
BR (1) BR9811937A (no)
CA (1) CA2301267C (no)
CZ (1) CZ293666B6 (no)
DE (1) DE69808303T2 (no)
DK (1) DK1003528T3 (no)
EE (1) EE04263B1 (no)
ES (1) ES2179523T3 (no)
HU (1) HU226823B1 (no)
ID (1) ID24463A (no)
IL (1) IL134521A (no)
NO (1) NO325148B1 (no)
NZ (1) NZ502133A (no)
OA (1) OA11287A (no)
PL (1) PL191607B1 (no)
PT (1) PT1003528E (no)
RU (1) RU2197967C2 (no)
SK (1) SK283868B6 (no)
TR (1) TR200000419T2 (no)
TW (1) TWI240633B (no)
UA (1) UA64765C2 (no)
WO (1) WO1999008690A1 (no)
ZA (1) ZA987221B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
DK0998272T3 (da) * 1997-08-26 2003-08-25 Aventis Pharma Inc Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
BR0306329A (pt) * 2002-05-29 2005-04-26 Aventis Pharmaceuticals Holdin Método de tratamento de asma
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
PE20060416A1 (es) * 2004-08-03 2006-06-09 Novartis Ag Composicion de inhibidores de renina e inhibidores de proteinas de efusion
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
PH12013502368A1 (en) 2011-05-20 2014-01-06 Aventisub Llc Pharmaceutical composition comprising fexofenadine
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
KR910007515A (ko) * 1989-01-31 1991-05-30 호르스트 카베리쯔 부식에 의한 활성제의 서방형 제제 및 그 제조방법
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds

Also Published As

Publication number Publication date
ZA987221B (en) 1999-02-15
OA11287A (en) 2003-10-22
RU2197967C2 (ru) 2003-02-10
EE04263B1 (et) 2004-04-15
CZ293666B6 (cs) 2004-06-16
CN1143680C (zh) 2004-03-31
ES2179523T3 (es) 2003-01-16
DK1003528T3 (da) 2003-02-03
SK283868B6 (sk) 2004-03-02
CZ2000522A3 (cs) 2000-09-13
EP1003528B1 (en) 2002-09-25
CA2301267C (en) 2004-07-13
CN1267221A (zh) 2000-09-20
HU226823B1 (hu) 2009-11-30
KR100522985B1 (ko) 2005-10-21
KR20010022845A (ko) 2001-03-26
CA2301267A1 (en) 1999-02-25
ATE224721T1 (de) 2002-10-15
AU8505098A (en) 1999-03-08
NZ502133A (en) 2002-03-28
PT1003528E (pt) 2003-02-28
TR200000419T2 (tr) 2000-09-21
TWI240633B (en) 2005-10-01
NO325148B1 (no) 2008-02-11
AR018505A1 (es) 2001-11-28
IL134521A (en) 2005-07-25
BR9811937A (pt) 2000-09-05
HUP0003189A2 (en) 2001-03-28
SK1842000A3 (en) 2000-08-14
PL338579A1 (en) 2000-11-06
PL191607B1 (pl) 2006-06-30
AU725965C (en) 2004-04-22
ID24463A (id) 2000-07-20
JP2001515041A (ja) 2001-09-18
HK1025901A1 (en) 2000-12-01
EP1003528A1 (en) 2000-05-31
DE69808303D1 (de) 2002-10-31
DE69808303T2 (de) 2003-05-22
JP4295913B2 (ja) 2009-07-15
NO20000706D0 (no) 2000-02-11
AU725965B2 (en) 2000-10-26
EE200000069A (et) 2000-10-16
HUP0003189A3 (en) 2001-04-28
UA64765C2 (uk) 2004-03-15
IL134521A0 (en) 2001-04-30
WO1999008690A1 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
FI950800L (fi) Menetelmä heterosyklisten yhdisteiden sulfinyloimiseksi
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
NO20011886D0 (no) Utforminger av fexofenadin
EE9900517A (et) Tsüklooksügenaas-2 inhibiitorite kasutamise meetod südameveresoonkonna haiguste ärahoidmiseks
EE04277B1 (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
NO20000706L (no) Metode for økning av biotilgjengeligheten av fexofenadin og dens derivater
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
IL134991A0 (en) Method for the synthesis of quinoline derivatives
NO20024060L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO993863D0 (no) Forbindelser og fremgangsmåte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
PL339304A1 (en) Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
UA25541A (uk) Спосіб обробки бочкоподібhих зубців
SE9903010D0 (sv) Method for screening
UA26025C2 (uk) Спосіб одержаhhя портлаhдцемеhтhого кліhкеру
UA25260A (uk) Спосіб отримаhhя 2-феhіл-3-карбетокси-5-гідроксибеhзофураhу

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: AVENTISUB LLC, US

MK1K Patent expired